These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15726102)

  • 21. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.
    Moss SM; Cuckle H; Evans A; Johns L; Waller M; Bobrow L;
    Lancet; 2006 Dec; 368(9552):2053-60. PubMed ID: 17161727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
    Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
    Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial.
    Frisell J; Lidbrink E; Hellström L; Rutqvist LE
    Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of screening mammography on breast cancer mortality: Quasi-experimental evidence from rollout of the Dutch population-based program with 17-year follow-up of a cohort.
    Van Ourti T; O'Donnell O; Koç H; Fracheboud J; de Koning HJ
    Int J Cancer; 2020 Apr; 146(8):2201-2208. PubMed ID: 31330046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
    Andersson I; Aspegren K; Janzon L; Landberg T; Lindholm K; Linell F; Ljungberg O; Ranstam J; Sigfússon B
    BMJ; 1988 Oct; 297(6654):943-8. PubMed ID: 3142562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of two view and one view mammography in the detection of small invasive cancers: results from the National Health Service breast screening programme.
    Blanks RG; Moss SM; Wallis MG
    J Med Screen; 1996; 3(4):200-3. PubMed ID: 9041485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of hybrid digital breast tomosynthesis/digital mammography compared to digital mammography in women presenting for routine screening at Maroondah BreastScreen: Study protocol for a co-designed, non-randomised prospective trial.
    Houssami N; Lockie D; Giles M; Doncovio S; Marr G; Taylor D; Li T; Nickel B; Marinovich ML
    Breast; 2024 Apr; 74():103692. PubMed ID: 38422623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research.
    Breast Screening Frequency Trial Group
    Eur J Cancer; 2002 Jul; 38(11):1458-64. PubMed ID: 12110490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
    Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
    Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening.
    Wald NJ; Murphy P; Major P; Parkes C; Townsend J; Frost C
    BMJ; 1995 Nov; 311(7014):1189-93. PubMed ID: 7488893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.
    FH01 collaborative teams
    Lancet Oncol; 2010 Dec; 11(12):1127-34. PubMed ID: 21093374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer.
    Lancet; 1999 Jun; 353(9168):1909-14. PubMed ID: 10371568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Updated results of the Gothenburg Trial of Mammographic Screening.
    Bjurstam NG; Björneld LM; Duffy SW
    Cancer; 2016 Jun; 122(12):1832-5. PubMed ID: 27061821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme.
    Dibden A; Offman J; Parmar D; Jenkins J; Slater J; Binysh K; McSorley J; Scorfield S; Cumming P; Liao XH; Ryan M; Harker D; Stevens G; Rogers N; Blanks R; Sellars S; Patnick J; Duffy SW
    Br J Cancer; 2014 Feb; 110(3):560-4. PubMed ID: 24366303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-view versus single-view mammography at subsequent screening in a region of the Dutch breast screening programme.
    van Breest Smallenburg V; Duijm LE; den Heeten GJ; Groenewoud JH; Jansen FH; Fracheboud J; Plaisier ML; van Doorne-Nagtegaal HJ; Broeders MJ
    Eur J Radiol; 2012 Sep; 81(9):2189-94. PubMed ID: 21906898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.